Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
Histochem Cell Biol ; 161(6): 477-491, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38641701

ABSTRACT

Chemotherapy-induced alopecia (CIA) represents one of the most severe side effects of chemotherapy, which forces some patients to reject cancer treatment. The exact pathophysiological mechanisms of CIA are not clearly understood, which makes it difficult to discover efficient preventive or therapeutic procedures for this adverse effect. N-acetylcysteine (NAC) has a strong antioxidant activity as it stimulates glutathione synthesis and acts as an oxygen radical scavenger. The current study tried to investigate the efficacy of NAC in preserving biochemical parameters and hair follicle structure against cyclophosphamide (CYP) administration. In total, 40 adult female C57BL/6 mice were induced to enter anagen by depilation (day 0) and divided into four groups: group I (control), group II (CYP) received a single dose of CYP [150 mg/kg body weight (B.W.)/intraperitoneal injection (IP)] at day 9, group III (CYP & NAC) received a single dose of CYP at day 9 as well as NAC (500 mg/kg B.W./day/IP) from day 6-16, and group IV (NAC) received NAC from day 6-16. CYP administration in group II induced an increase in malondialdehyde (MDA), decrease in superoxide dismutase (SOD), histological hair follicle dystrophy, disruption of follicular melanogenesis, overexpression of p53, and loss of ki67 immunoreactivity. NAC coadministration in group III reversed CYP-induced alterations in the biochemical parameters and preserved hair follicle structure, typical follicular melanin distribution as well as normal pattern of p53 and ki67 expression. These findings indicated that NAC could be used as an efficient and safe therapeutic option for hair loss induced by chemotherapy.


Subject(s)
Acetylcysteine , Alopecia , Cyclophosphamide , Disease Models, Animal , Hair Follicle , Mice, Inbred C57BL , Animals , Alopecia/chemically induced , Alopecia/drug therapy , Alopecia/pathology , Alopecia/metabolism , Mice , Hair Follicle/metabolism , Hair Follicle/drug effects , Hair Follicle/pathology , Female , Acetylcysteine/pharmacology , Antineoplastic Agents, Alkylating
2.
Pharmaceuticals (Basel) ; 16(5)2023 Apr 27.
Article in English | MEDLINE | ID: mdl-37242441

ABSTRACT

Ethanol-producing dysbiotic gut microbiota could accelerate the progress of non-alcoholic fatty liver disease (NAFLD). Metformin demonstrated some benefits in NAFLD. In the present study, we tested the ability of metformin to modify ethanol-producing gut bacterial strains and, consequently, retard the progress of NAFLD. This 12-week study included forty mice divided into four groups (n = 10); normal diet, Western diet, Western diet with intraperitoneal metformin, and Western diet with oral metformin. Oral metformin has a slight advantage over intraperitoneal metformin in ameliorating the Western diet-induced changes in liver function tests and serum levels of different cytokines (IL-1ß, IL-6, IL-17, and TNF-α). Changes in liver histology, fibrosis, lipid content, Ki67, and TNF-α were all corrected as well. Faecal ethanol contents were increased by the Western diet but did not improve after treatment with metformin although the numbers of ethanol-producing Klebsiella pneumoniae (K. pneumoniae) and Escherichia coli (E. coli) were decreased by oral metformin. Metformin did not affect bacterial ethanol production. It does not seem that modification of ethanol-producing K. pneumoniae and E. coli bacterial strains by metformin could have a significant impact on the therapeutic potentials of metformin in this experimental model of NAFLD.

3.
Tissue Barriers ; 11(1): 2019504, 2023 Jan 02.
Article in English | MEDLINE | ID: mdl-34939895

ABSTRACT

Doxorubicin (Dox) is an anthracycline antibiotic that treats a variety of malignancies. Unfortunately, its cardiotoxicity limits its therapeutic usefulness. Coenzyme Q10 (CoQ10) has effectively treated and prevented various cardiac diseases and toxicities. This study aimed to evaluate the possible antioxidative and anti-apoptotic cardioprotective effects of CoQ10 against doxorubicin-induced histopathological and molecular changes in cardiomyocytes. Twenty-eight adult Wistar rats were divided into positive control, negative control, Dox-treated group, and Dox+CoQ10-treated. On the 16th day after the start of treatment, the hearts of all rats were dissected, and the left ventricles were processed for histological evaluation; immunohistochemical staining with caspase-3 and inducible nitric oxide synthase (iNOS); ultrastructural examination of cardiomyocytes; molecular assessment of proapoptotic gene Bax and anti-apoptotic gene expression Bcl-2; and biochemical study of malondialdehyde (MDA). The Dox-treated group had disorganized cardiomyocytes with increased interstitial space, vacuolated cytoplasm, and multiple small-sized pyknotic nuclei. A significant increase in caspase-3 and iNOS immunoexpression was observed. Ultrastructurally, the mitochondria were large with abnormal shapes, vacuolated cytoplasm, multiple vacuoles and autophagosomes, collagen fibril accumulation, and multiple small hyperchromatic nuclei. The intercalated discs were disorganized with loss of desmosome junction. The cardiomyocytes also showed significantly increased MDA levels and upregulation of Bax/Bcl-2 gene expression ratio. Co-administration of CoQ10 resulted in significant improvement in the histopathological picture, with a significant decrease in caspase-3 and iNOS immunoexpression and downregulation of the Bax/Bcl-2 gene expression ratio. In conclusion, CoQ10 protects against Dox-induced cardiotoxicity through the regulation of proapoptotic and anti-apoptotic gene expression.


Subject(s)
Antioxidants , Cardiomyopathies , Rats , Animals , Antioxidants/pharmacology , Antioxidants/therapeutic use , Caspase 3/metabolism , Caspase 3/therapeutic use , Cardiotoxicity/drug therapy , Cardiotoxicity/metabolism , Rats, Wistar , bcl-2-Associated X Protein/therapeutic use , Cardiomyopathies/chemically induced , Cardiomyopathies/prevention & control , Doxorubicin/adverse effects , Proto-Oncogene Proteins c-bcl-2/metabolism , Proto-Oncogene Proteins c-bcl-2/therapeutic use
4.
Oxid Med Cell Longev ; 2021: 9690047, 2021.
Article in English | MEDLINE | ID: mdl-34630855

ABSTRACT

BACKGROUND: Oral mucositis is the most debilitating and troublesome adverse effect of irinotecan (CPT-11) treatment. It adversely affects the patient quality of life. The aim of this work was to study the histological, immunohistochemical, and molecular changes in the oral mucosa by CPT-11 and the possible alleviated role of atorvastatin. METHODS: Rats were randomly divided into control, CPT-11-treated group, and CPT-11+ atorvastatin-treated group. At the end of the experiment, the anterior two-thirds of the tongue was dissected out and divided into two parts: one part for light microscopic examination and the second for molecular study. RESULTS: CPT-11-treated group revealed loss of normal mucosal organization, areas of ulceration and inflammation, and loss of architecture of lingual papillae. A significant decrease in immunohistochemical and molecular gene expression of Ki-67 and antiapoptotic Bcl-2 levels was observed. A significant increase in NF-κB immunohistochemical and mRNA gene expression level and a nonsignificant increase in Nrf2 gene expression were detected. Coadministration of atorvastatin showed remarkable improvement in the histopathological picture with a significant increase in Ki-67 and Bcl-2, a significant decrease in NF-κB protein and gene expression, and a significant increase in Nrf2 gene expression. CONCLUSION: Atorvastatin substantially attenuates CPT-11-induced oral mucositis through the initiation of the antiapoptotic gene, modulation of the inflammatory, and antioxidant gene expression.


Subject(s)
Antineoplastic Agents/adverse effects , Antioxidants/administration & dosage , Atorvastatin/administration & dosage , Irinotecan/adverse effects , Mouth Mucosa/drug effects , Stomatitis/chemically induced , Stomatitis/drug therapy , Tongue/drug effects , Animals , Gene Expression/drug effects , Ki-67 Antigen/genetics , Ki-67 Antigen/metabolism , Male , Mouth Mucosa/metabolism , NF-E2-Related Factor 2/genetics , NF-kappa B/genetics , NF-kappa B/metabolism , Proto-Oncogene Proteins c-bcl-2/genetics , Proto-Oncogene Proteins c-bcl-2/metabolism , Random Allocation , Rats , Rats, Sprague-Dawley , Signal Transduction/drug effects , Stomatitis/genetics , Stomatitis/metabolism , Tongue/metabolism , Treatment Outcome
5.
Clin Exp Pharmacol Physiol ; 48(5): 791-800, 2021 05.
Article in English | MEDLINE | ID: mdl-33634509

ABSTRACT

Dedifferentiation of tubular epithelial cells is involved in both regeneration and fibrosis following acute kidney injury (AKI). Prostaglandin E2 receptor 4 (EP4 ) antagonist can inhibit the dedifferentiation of renal tubular cells. The present study investigated whether the time of blockage of EP4 receptors, using grapiprant, could affect the tubular regeneration or interstitial fibrosis in AKI. Cisplatin was used to induce AKI in 72 C57BL/6 adult female mice. Animals were assigned to four groups; control, cisplatin-treated, cisplatin-treated with early grapiprant intervention and cisplatin-treated with late grapiprant intervention. AKI was assessed by kidney function tests and histopathology. Fibrosis was evaluated by Masson's trichrome and alpha smooth muscle actin (α-SMA) expression. Markers of dedifferentiation, CD133, and epithelial to mesenchymal transition (EMT), vimentin were assessed. Early intervention with grapiprant significantly ameliorated AKI more efficiently than late intervention. However, even late intervention was useful in reducing the overall fibrosis as demonstrated by Masson's trichrome and α-SMA expression. In both grapiprant-treated groups, a parallel reduction of dedifferentiation (CD133) and EMT (vimentin) was evident. It seems that the progressive fibrotic changes that follow AKI could still be reduced possibly by targeting dedifferentiation and/or EMT.


Subject(s)
Acute Kidney Injury , Epithelial-Mesenchymal Transition , Animals , Fibrosis , Male , Mice , Prostaglandins
6.
Cells ; 11(1)2021 12 24.
Article in English | MEDLINE | ID: mdl-35011610

ABSTRACT

Fibromyalgia (FM) is a common chronic pain syndrome that affects 1% to 5% of the population. We aimed to investigate the role of endothelial dysfunction and autophagy in fibromyalgia-related vascular and cerebral cortical changes in a reserpine-induced rat model of fibromyalgia at the histological and molecular levels and to study the ameliorative effect of fisetin. Forty adult female albino rats were divided into four groups (10 each): two control groups, the reserpine-induced fibromyalgia group, and the fisetin-treated group. The carotid arteries and brains of the animals were dissected. Frozen tissue samples were used for total RNA extraction and qPCR analysis of eNOS, caspase-3, Bcl-2, LC-3, BECN-1, CHOP, and TNF-α expression. Histological, immunohistochemical (eNOS), and ultrastructure studies were conducted. The carotid arteries revealed excessive autophagy and endothelial, vascular, and apoptotic changes. The cerebral cortex showed similar findings apart from endoplasmic reticulum stress. Additionally, there was decreased gene expression of eNOS and Bcl-2 and increased expression of caspase-3, LC-3, BECN-1, CHOP, and TNF-α. In the fisetin-treated rats, improvements in the histological and molecular results were detected. In conclusion, oxidative stress, enhanced apoptosis, and excessive autophagy are fundamental pathophysiologic mechanisms of reserpine-induced fibromyalgia. Moreover, fisetin has an ameliorative effect against fibromyalgia.


Subject(s)
Autophagy , Blood Vessels/pathology , Blood Vessels/physiopathology , Cerebral Cortex/pathology , Endothelium, Vascular/physiopathology , Fibromyalgia/complications , Flavonols/pharmacology , Animals , Autophagy/drug effects , Blood Vessels/drug effects , Carotid Arteries/drug effects , Carotid Arteries/pathology , Carotid Arteries/physiopathology , Carotid Arteries/ultrastructure , Cerebral Cortex/drug effects , Endothelium, Vascular/drug effects , Female , Nitric Oxide Synthase Type III/metabolism , Rats, Sprague-Dawley
7.
Histochem Cell Biol ; 153(1): 49-62, 2020 Jan.
Article in English | MEDLINE | ID: mdl-31637472

ABSTRACT

Endoplasmic reticulum (ER) stress could participate in high-fat diet (HFD)-induced hepatic steatosis. The current study aims to investigate the role of ER stress as well as inflammation as possible pathophysiologic mechanisms of HFD-induced hepatic steatosis at ultrastructure and molecular levels. Fifteen control rats on ordinary diet and 30 HFD-fed rats were enrolled in the study. Histological and EM examinations of rats' liver were carried out. Molecular study of TNF-α, CRP, and HNF4α by RT qPCR as well as biochemical investigation of liver function and lipids profile were done. Hepatic steatosis was induced with lipid droplets accumulation at histological level and mega-mitochondria with reduced ER-mitochondrial distance at EM level. Increased gene expression of TNF-α and CRP was significantly correlated with the reduced HNF4α expression and with other ER stress markers. In conclusion, endoplasmic reticulum stress, confirmed at ultrastructure level, plays an important role in pathogenesis of HFD-induced hepatic steatosis. HNF4α downregulation as well as increased expression of hs-CRP and TNF-α enforce the concept of interplay between ER stress, hepatic subclinical inflammation, and disturbed gene expression regulation in the pathogenesis of HFD-induced hepatic steatosis.


Subject(s)
Endoplasmic Reticulum Stress , Fatty Liver/metabolism , Hepatocyte Nuclear Factor 4/metabolism , Inflammation Mediators/metabolism , Animals , Diet, High-Fat/adverse effects , Disease Models, Animal , Inflammation/metabolism , Inflammation/physiopathology , Male , Rats , Rats, Sprague-Dawley
8.
Biotech Histochem ; 95(1): 55-68, 2020 Jan.
Article in English | MEDLINE | ID: mdl-31570007

ABSTRACT

The mother-infant relation is important for brain development and maturation. To investigate hippocampus changes, we used 18 male rat pups from three dams. Pups were divided into a maternal care (control) group, a maternal separation (MS) group and a MS plus fluoxetine (MS + Fl) treated group. On postnatal day 22, pups were weaned and their serum corticosterone level measured. At 2 months, the hippocampus was removed and processed for histological, immunohistochemical and ultrastructural study. MS caused significant elevation of serum corticosterone level and a significant decrease in the thickness of the pyramidal and granular layers of the cornu ammonis 3 (CA3) and dentate gyrus (DG) areas of the hippocampus. Both CA3 and DG areas exhibited degenerative changes in nerve cells, which were shrunken with pyknotic nucleus and darkly stained cytoplasm. Electron microscopy showed condensed chromatin, degenerated mitochondria, cytoplasmic vacuoles and electron lucent cytoplasm with loss of most polyribosomes. Immunohistochemical staining showed significantly increased numbers of glial fibrillary acid protein-positive cells in the CA3 and DG, and numbers of Ki-67stained cells in the DG in the MS group compared to the control group. All adverse changes were ameliorated in the MS + Fl group. Our findings corroborate the importance of the mother-infant relation to hippocampal development and demonstrate a protective role for Fl in MS pups.


Subject(s)
Fluoxetine/therapeutic use , Hippocampus/drug effects , Hippocampus/injuries , Selective Serotonin Reuptake Inhibitors/therapeutic use , Animals , Cortisone/blood , Female , Male , Rats
9.
Acta Histochem ; 121(7): 841-851, 2019 Oct.
Article in English | MEDLINE | ID: mdl-31431301

ABSTRACT

Autism Spectrum Disorder (ASD) is a heterogeneous neurodevelopmental disease characterized by defect in verbal and nonverbal communications. As, the cerebellum has the greatest number of neurons and synapses in the central nervous system so, the cerebellum has emerged as one of the target brain areas affected in autism. The aim of this work was to study the biochemical, immunohistochemical and ultrastructural characteristics of autism and the possible neuroprotective role of grape seed extract. In this study 28 male pups were divided into Control groups; Group I (saline), Group II (GSE 400 mg/kg), Group III (VPA 500 mg/kg) and Group IV (VPA and GSE). Cerebellar hemispheres were dissected out and prepared to determine the oxidative stress markers, histological, immunohistochemical and morphometric study were done. A significant elevation in oxidative stress markers in off spring of VPA treated rats in comparison to control group was detected. A significant decrease in the Purkinje cell count and nuclear size were observed. Numerous shrunken cells with hyperchromatic nuclei and ultrastructural degeneration of cytoplasmic organelles were detected. A significant rise in the area percentage of GFAP-positive immune stained cells in comparison to that of the control groups was seen. Strikingly, GSE revealed significant improvement in the oxidative stress markers and then the histological and morphometric picture of the cerebellum. GSE has neuroprotective effect on the cerebellum of VPA treated rats through its potent antioxidant effect.


Subject(s)
Autistic Disorder , Cerebellar Cortex , Neuroprotective Agents/pharmacology , Plant Extracts/pharmacology , Prenatal Exposure Delayed Effects , Seeds/chemistry , Valproic Acid/adverse effects , Vitis/chemistry , Animals , Autistic Disorder/chemically induced , Autistic Disorder/metabolism , Autistic Disorder/pathology , Autistic Disorder/prevention & control , Cerebellar Cortex/metabolism , Cerebellar Cortex/pathology , Disease Models, Animal , Female , Neuroprotective Agents/chemistry , Plant Extracts/chemistry , Pregnancy , Prenatal Exposure Delayed Effects/chemically induced , Prenatal Exposure Delayed Effects/metabolism , Prenatal Exposure Delayed Effects/pathology , Prenatal Exposure Delayed Effects/prevention & control , Rats , Valproic Acid/pharmacology
10.
Cutis ; 97(3): 235-41, 2016 Mar.
Article in English | MEDLINE | ID: mdl-27023086

ABSTRACT

Psoriasis is a chronic inflammatory disease that has been associated with an increased incidence of insulin resistance and diabetes mellitus (DM). Tumor necrosis factor (TNF) α inhibitors and IL-6 blockers, which are routinely used for the treatment of psoriasis, have been positively associated with insulin sensitivity. The aim of this study was to assess the effects of treatment with TNF-α inhibitors on insulin sensitivity in psoriatic patients with type 2 DM. This study confirms a beneficial effect of anti-TNF-α agents on insulin resistance and insulin sensitivity in psoriasis patients with type 2 DM.


Subject(s)
Dermatologic Agents/pharmacology , Diabetes Mellitus, Type 2/physiopathology , Psoriasis/drug therapy , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Adolescent , Adult , Aged , Dermatologic Agents/therapeutic use , Female , Humans , Insulin Resistance , Male , Middle Aged , Prospective Studies , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...